Antonio Jimeno, MD
Medical Oncology · Aurora, CONPI 1508039991
Payments from drug & device makers
Across 749 payments — averaging $7484.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$2.5M
- Genentech, Inc.$1000K
- Modernatx, Inc.$904K
- E.r. Squibb & Sons, L.L.C.$633K
- Pfizer$185K
- EMD Serono, Inc.$107K
- plus $287K from 11 others
What the payments were for
- Consulting fees$1,38899%
- Education$121%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 351 | $2,489,636 |
| Genentech, Inc. | 92 | $999,600 |
| Modernatx, Inc. | 173 | $904,339 |
| E.r. Squibb & Sons, L.L.C. | 12 | $633,360 |
| Pfizer | 29 | $184,606 |
| EMD Serono, Inc. | 18 | $106,609 |
| AstraZeneca | 25 | $97,095 |
| Sanofi US Services Inc. | 4 | $52,602 |
| Merck Healthcare Kgaa | 14 | $48,460 |
| Iovance Biotherapeutics, Inc. | 15 | $33,133 |
| Bayer | 6 | $29,497 |
| Astrazeneca UK Limited | 4 | $14,979 |
| Organon | 1 | $6,656 |
| Acerta Pharma LLC | 1 | $2,186 |
| Janssen Scientific Affairs, LLC | 1 | $1,388 |
| Merck Kgaa | 2 | $1,380 |
| Karyopharm Therapeutics Inc. | 1 | $12 |
How this compares
$5,605,535 in reported general payments places this provider in the 90th percentile of 96 medical oncology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 60 | $391 |
| Dexamethasone | 28 | $281 |
| Prochlorperazine Maleate | 22 | $258 |
| Ondansetron Hcl | 25 | $203 |
| Omeprazole | 26 | $196 |
Paid to pharmacies, not to this prescriber.
Other medical oncology in Aurora
- Karl LewisAurora$12.4M
- Christopher LieuAurora$8M
- David CamidgeAurora$7.3M
- Theresa MedinaAurora$7M
- Wells MessersmithAurora$6.3M
- Elizabeth KesslerAurora$5.1M
- Sarah DavisAurora$3.9M
- Sunnie KimAurora$3.9M
- Peter KabosAurora$3.5M
- Robert LentzAurora$3.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.